PRODRUGS VON STAT3-INHIBITOREN
European patent · EP4539936 · In force
Register entry
- Publication number
- EP4539936
- Application number
- EP23738403
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jun 9, 2023
- Published
- Apr 23, 2025
- Granted
- Aug 19, 2026
- Protection ends at the latest
- Jun 8, 2043
- Next annual fee due
- Jun 30, 2027
- IPC classes
- C07F 9/12 (2006.01)C07F 9/6574 (2006.01)A61P 35/00 (2006.01)C07C 311/29 (2006.01)C07D 207/09 (2006.01)
- Priority
- US 202263366437 P 15.06.2022
- PCT application
- PCT/US2023/068240 09.06.2023
- PCT publication
- WO2023/244946 21.12.2023
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 30, 2026
Agent entered
- Representative
- HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel
Published in Swissreg on 30.09.2026
- Aug 26, 2026
Change
Published in Swissreg on 26.08.2026
- Aug 19, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 19.08.2026
Parties
Holder
Inventor
ALIBHAI, Imran
Sugar Land, Texas 77478, US
DE ACHAVAL, Sofia
Sugar Land, Texas 77478, US
LARSON, Jeffrey
Sugar Land, Texas 77478, US
HENKE, Brad
Raleigh, North Carolina 27609, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.